Program Description: 

This online educational activity will address the existing gap between the clinical need to remain up-to-date on current issues in Psychosomatic Medicine and available, accessible materials to meet this need. In the process, we will provide an opportunity for Maintenance of Certification (MOC) credit for Psychosomatic Medicine specialty certification through the American Board of Psychiatry and Neurology. We will offer four ouItstanding presentations from the Annual Meeting on the following topics:

Skills Courses:

  • Acute Brain Failure: Neurobiology, Prevention and Treatment of Delirium
  • Psychopharmacology: A Focused Review of Drug-Drug-Drug Interactions
  • Assessment and Management of the Opioid-Dependent Chronic Pain Patient
  • Legal Issues in Psychosomatic Medicine

The current system of graduate medical education is not prepared to meet this clinical, educational, and administrative need. There is limited continuing medical education in Psychosomatic Medicine and no other source for MOC training and credit in Psychosomatic Medicine. The members of the Academy of Psychosomatic Medicine, and the presenters at the Academy’s Annual Meeting, are uniquely trained at the interface of psychiatry and medicine, qualified to practice in these clinical settings, and prepared to provide this training.


Accreditation Statement:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of The Medical College of Wisconsin and Academy of Psychosomatic Medicine. The Medical College of Wisconsin is accredited by the ACCME to provide continuing medical education for physicians.
Designation of Credit Statement:
The Medical College of Wisconsin designates this Enduring Material for a maximum of 4.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hours of  Participation for Allied Health Professionals:
The Medical College of Wisconsin designates this activity for up to 4.0 hours of participation for continuing education for allied health professionals.  


Please note: The course fee is $7.50 in addition to a $2.50 processing fee which is assessed for all electronic registrations. 

Target audience: 
Nurse Practitioners
Practitioners in Patient Care Interested in C-L
Learning objectives: 
At the conclusion of this activity, participants will be able to:
  1. Assess the concept of clinical relevance when considering drug interactions
  2. Review and discuss drug interactions in terms of both class effects and individual interactions
  3. Describe the name some of the most common and potentially fatal psychotropic drug-drug interactions
Faculty & credentials: 
Planning committee:
John Shuster, MD, FAPM
Robert Boland, MD, FAPM
J. Michael Bostwick, MD, FAPM
Catherine Crone, MD, FAPM
Jeff Huffman, MD, FAPM



Sheryl B. Fleisch, MD
Assistant Professor of Psychiatry, Vanderbilt University Medical Center, Nashville, Tennessee
Daniel Elswick, MD
Residency and PM Fellowship PD, WVU, Morgantown, West Virginia
Jose R. Maldonado, MD, FAPM
Associate Professor of Psychiatry, Stanford University, Stanford, California
Yelizaveta I. Sher, MD
Clinical Assistant Professor, Stanford University Medical Center, Stanford, California
All persons in control of content have NO relevant financial relationships to disclose 


James Vrac, CAE
Phone number: 
+1 (301) 718-6523
  • 4.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 4.00 Hours of Participation
    Hours of Participation credit.

Please login or register to take this course.